ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 670226 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 670226; 2) Community: the network communities that were significantly associated with the response to NSC 670226; 3) Molecule: the relationships between components within communities and NSC 670226; 4) MDR: the compounds that were significantly associated with the NSC 670226.

NSC Compound Enrichment Correlation
NSC 33568 1-Propanone, 1,2-diphenyl-3-(1-piperidinyl)- (9CI) 0.017498903403062 0.19826058
NSC 40273 Null 0.017498903403062 0.14811757
NSC 405158 2,5-Cyclohexadiene-.delta.1,.alpha.-acetonitrile, .alpha.-(p-chlorophenyl)-4-oxo-, oxime 0.017498903403062 0.25723698
NSC 59937 Null 0.017498903403062 0.33612875
NSC 606985 Camptothecin Derivative 0.017498903403062 0.11330256
NSC 613327 Gemcitabine Y 0.017498903403062 0.11251853
NSC 618939 Camptothecin Derivative 0.017498903403062 0.10650415
NSC 624229 Null 0.017498903403062 0.24905891
NSC 646847 Bengamide G 0.017498903403062 0.19536987
NSC 659949 14-Bromo-7-O-(2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexo- pyranosyl)-4-demethoxydaunomycinone 0.017498903403062 0.15006713
Total:146  Current:62    [First] [Prev] [Next] [Last]